21 algorithm-development-"Prof"-"Washington-University-in-St"-"Prof" PhD positions in Switzerland
Sort by
Refine Your Search
-
from this research inform the development of new diagnostics, treatments, and vaccines against malaria, tuberculosis, schistosomiasis, Chagas and other neglected tropical diseases. Within the Parasite
-
at Empa in Dübendorf drives innovations in joining technologies and corrosion management to enable evolution towards increasingly efficient, reliable and sustainable material technologies. Joining
-
. The acquired and already existing database will be used to further develop ML models for the automated detection of clinically relevant markers. The goal is to develop the technique towards potential clinical
-
to advance our understanding of health and disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 900 employees
-
. Empa is a research institution of the ETH Domain. Empa's Laboratory for High Performance Ceramics is involved in the scientific research, development and characterization of advanced ceramics, composites
-
that promotes independent thinking and an environment that inspires excellence. Located in the heart of Europe, yet forging connections all over the world, we work together to develop solutions
-
promising junior researchers in developing a PhD project to apply for follow-up funding. The Doctoral Program in Literary Studies The international, interphilological Doctoral Program in Literary Studies
-
writing skills. The capacity to work effectively in an international team. We offer Mentoring and support for professional and personal development; opportunity to work with members with diverse backgrounds
-
. Applicants are advised to prepare their applications carefully, as admissions to EPFL PhD programs are highly competitive. Admission If you qualify, you will have to register in the Doctoral School within a
-
outcomes and inclusive device development across diverse patient populations. The project involves international collaboration with partners in the United Kingdom (UK) and Germany. It employs a biomedical